Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D M Roden

Showing results (161-170 of 237) with videos related to

Pageof 24
Sort By:
The American Journal of Cardiology|January 15, 1992
Pharmacology of the class III antiarrhythmic agent sematilide in patients with arrhythmiasW Wong, H N Pavlou, U M Birgersdotter, et al.
The American Journal of Cardiology|November 15, 1985
Spectrum of antiarrhythmic response to encainideH J Duff, D M Roden, E L Carey, et al.
Clinical Pharmacology and Therapeutics|September 16, 2011
Pharmacogenomics: application to the management of cardiovascular diseaseJ A Johnson, L H Cavallari, A L Beitelshees, et al.
Circulation|December 16, 1998
Modulation by dietary salt of verapamil disposition in humansD Darbar, M F Fromm, S Dell'Orto, et al.
Circulation Research|February 5, 1999
Replacement by homologous recombination of the minK gene with lacZ reveals restriction of minK expression to the mouse cardiac conduction systemS Kupershmidt, T Yang, M E Anderson, et al.
Clinical Pharmacology and Therapeutics|March 1, 1986
Co-inheritance of the polymorphic metabolism of encainide and debrisoquinR L Woosley, D M Roden, G H Dai, et al.
Circulation|August 1, 1983
Electrophysiologic actions of O-demethyl encainide: an active metaboliteH J Duff, A K Dawson, D M Roden, et al.
The American Journal of Cardiology|August 1, 1982
Comparison of the effects of placebo and encainide on programmed electrical stimulation and ventricular arrhythmia frequencyH J Duff, D M Roden, A K Dawson, et al.
Circulation|September 6, 2001
Gating-dependent mechanisms for flecainide action in SCN5A-linked arrhythmia syndromesP C Viswanathan, C R Bezzina, A L George, et al.
Journal of Cardiovascular Pharmacology|September 1, 1989
Pharmacokinetic and pharmacodynamic interaction of N-acetyl procainamide and procainamide in humansC Funck-Brentano, R T Light, M D Lineberry, et al.
Pageof 24

Showing results (161-170 of 237) with videos related to

Sort By:
Pageof 24
The American Journal of Cardiology|January 15, 1992
Pharmacology of the class III antiarrhythmic agent sematilide in patients with arrhythmiasW Wong, H N Pavlou, U M Birgersdotter, et al.
The American Journal of Cardiology|November 15, 1985
Spectrum of antiarrhythmic response to encainideH J Duff, D M Roden, E L Carey, et al.
Clinical Pharmacology and Therapeutics|September 16, 2011
Pharmacogenomics: application to the management of cardiovascular diseaseJ A Johnson, L H Cavallari, A L Beitelshees, et al.
Circulation|December 16, 1998
Modulation by dietary salt of verapamil disposition in humansD Darbar, M F Fromm, S Dell'Orto, et al.
Circulation Research|February 5, 1999
Replacement by homologous recombination of the minK gene with lacZ reveals restriction of minK expression to the mouse cardiac conduction systemS Kupershmidt, T Yang, M E Anderson, et al.
Clinical Pharmacology and Therapeutics|March 1, 1986
Co-inheritance of the polymorphic metabolism of encainide and debrisoquinR L Woosley, D M Roden, G H Dai, et al.
Circulation|August 1, 1983
Electrophysiologic actions of O-demethyl encainide: an active metaboliteH J Duff, A K Dawson, D M Roden, et al.
The American Journal of Cardiology|August 1, 1982
Comparison of the effects of placebo and encainide on programmed electrical stimulation and ventricular arrhythmia frequencyH J Duff, D M Roden, A K Dawson, et al.
Circulation|September 6, 2001
Gating-dependent mechanisms for flecainide action in SCN5A-linked arrhythmia syndromesP C Viswanathan, C R Bezzina, A L George, et al.
Journal of Cardiovascular Pharmacology|September 1, 1989
Pharmacokinetic and pharmacodynamic interaction of N-acetyl procainamide and procainamide in humansC Funck-Brentano, R T Light, M D Lineberry, et al.
Pageof 24